Evidence map›Paper›PMID 33859524›Full record

ArticleInternational journal of medical sciences2021

A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms.

Andrea Frilling, Ashley K Clift, Adam E Frampton, Jamshed Bomanji, Daniel Kaemmerer, Adil Al-Nahhas, Ali Alsafi, Mark Kidd, Irvin M Modlin, Dieter Hoersch and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. New Insights in PRRT: Lessons From 2021.Frontiers in endocrinology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrea FrillingDepartment of Surgery and Cancer, Imperial College London, London, UK.
Ashley K CliftDepartment of Surgery and Cancer, Imperial College London, London, UK.
Adam E FramptonDepartment of Surgery and Cancer, Imperial College London, London, UK.
Jamshed BomanjiDepartment of Nuclear Medicine, University College London Hospitals, London, UK.
Daniel KaemmererDepartment of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany.
Adil Al-NahhasDepartment of Imaging and Nuclear Medicine, Imperial College London, London, UK.
Ali AlsafiDepartment of Imaging and Nuclear Medicine, Imperial College London, London, UK.
Mark KiddWREN Laboratories, Branford, USA.
Irvin M ModlinGastroenterological and Endoscopic Surgery, Yale University School of Medicine, New Haven, USA.
Dieter HoerschDepartment of Gastroenterology/Endocrinology, Zentralklinik Bad Berka, Bad Berka, Germany.
Richard P BaumCURANOSTICUM Wiesbaden-Frankfurt at DKD Helios Klinik, Wiesbaden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleFollow-Up StudiesHumansIntestinal NeoplasmsKaplan-Meier EstimateLiquid BiopsyMaleMiddle AgedNeuroendocrine TumorsOctreotideOrganometallic CompoundsPositron Emission Tomography Computed TomographyPrecision MedicineProgression-Free Survivallutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadiopharmaceuticalsmRNAmultianalyte gene biomarker.NETestNeuroendocrine neoplasiapeptide receptor radionuclide therapysmall bowelsurgery

Identifiers

PMID33859524
PMCPMC8040427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.